A correlation between LP-PLA2 and monocyte levels in atherosclerosis risk subjects (original) (raw)
Lp-PLA2 levels are independant of statin treatment in dyslipidemic patients
D. Bonnefont-Rousselot
Atherosclerosis, 2015
View PDFchevron_right
The epidemiology of Lp-PLA2: Distribution and correlation with cardiovascular risk factors in a population-based cohort
Margaretha Persson
Atherosclerosis, 2007
View PDFchevron_right
Lp-PLA2—A novel marker of atherosclerosis: To treat or not to treat?
Dimitris Tousoulis, Nikolaos Papageorgiou
International Journal of Cardiology, 2013
View PDFchevron_right
Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes
Valgerdur Steinthorsdottir
Journal of the American College of Cardiology, 2019
View PDFchevron_right
Elevated Lp(a) Levels Correlate with Severe and Multiple Coronary Artery Stenotic Lesions
Daniel Platt
Vascular Health and Risk Management, 2023
View PDFchevron_right
Association between Lp-PLA 2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis
Natalie Khuseyinova
Atherosclerosis, 2005
View PDFchevron_right
The Role Of Inflammation In Atherosclerosis
Fatma Saaoud
2017
View PDFchevron_right
Lp-PLA2 and risk of atherosclerotic vascular disease
Robert Rosenson
The Lancet, 2010
View PDFchevron_right
Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis
carole grenier
Nature Communications, 2017
View PDFchevron_right
Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease
Stavros Tzortzis
Atherosclerosis, 2014
View PDFchevron_right
Severity of coronary atherosclerosis related to lipoprotein concentration
Richard W Harper
BMJ, 1978
View PDFchevron_right
Monocyte Gene Expression Signature of Patients with Early Onset Coronary Artery Disease
Alison Goodall
PLoS ONE, 2012
View PDFchevron_right
Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women
Luisa Bernardinelli
Journal of Thrombosis and Haemostasis, 2005
View PDFchevron_right
Lipoprotein(a), Inflammation, and Peripheral Arterial Disease in a Community-Based Sample of Older Men and Women (the InCHIANTI Study)
Luigi Ferrucci
The American Journal of Cardiology, 2010
View PDFchevron_right
Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease
Angela Ren
Journal of the American College of Cardiology, 2014
View PDFchevron_right
Editorial: Targeting Monocytes/Macrophages to Treat Atherosclerotic Inflammation
Alfonso Pompella
Frontiers in Pharmacology, 2020
View PDFchevron_right
ELEVATED LIPOPROTEIN (a) LEVELS SEEN IN PATIENTS WITH CORONARY ARTERY DISEASE
Prof. Iram Fayyaz
…, 2009
View PDFchevron_right
Increased Platelet Reactivity Is Associated with Circulating Platelet-Monocyte Complexes and Macrophages in Human Atherosclerotic Plaques
Andrew Stubbs
PLoS ONE, 2014
View PDFchevron_right
Increased Platelet Reactivity and Circulating Monocyte-Platelet Aggregates in Patients With Stable Coronary Artery Disease
Stephen Benoit
Journal of the American College of Cardiology, 1998
View PDFchevron_right
On the present and future role of Lp-PLA2 in atherosclerosis-related cardiovascular risk prediction and management
Zlatko FRAS
Archives of Medical Science
View PDFchevron_right
Secretory Phospholipase A2-IIA and Cardiovascular Disease
Alain Tedgui
Journal of the American College of Cardiology, 2013
View PDFchevron_right
Comparison of Serum LP-PLA2 Level and some Nutritional Factors between Well-Controlled and Poorly-Controlled Diabetic Patients
Mahnaz Zarei
Acta medica Iranica, 2015
View PDFchevron_right
Lp-PLA2, a new biomarker of vascular disorders in metabolic diseases
Liliana Mannucci
International Journal of Immunopathology and Pharmacology, 2019
View PDFchevron_right
The role of Lp-PLA2 and biochemistry parameters as potential biomarkers of coronary artery disease in Asian South-Indians: a case-control study
Sai Giridhar Sairam
Cardiovascular Diagnosis and Therapy
View PDFchevron_right
Lipoprotein (a): molecular and epidemiologic basis about its role in cardiovascular diseases
valmore bermudez
Revista …, 2008
View PDFchevron_right
Elevated Lp-PLA2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects
Margaretha Persson
Arteriosclerosis, Thrombosis, and Vascular Biology, 2007
View PDFchevron_right
Role of Macrophages in Regression of Atherosclerosis
assaad daoud
Annals of the New York Academy of Sciences, 1985
View PDFchevron_right
Low dose LPS does not increase TLR4 expression on monocytes in a human in vivo model
Philipp Kobbe
Cytokine, 2013
View PDFchevron_right
Lp-PLA2: A new target for statin therapy
Lynne Braun
Current atherosclerosis reports, 2010
View PDFchevron_right
Lipoprotein-Associated Phospholipase A2 and Cardiovascular Risk: State of the Evidence and Future Directions
Carolina Prieto
Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
View PDFchevron_right
Effect of platelet-activating factor on lipoprotein lipase and blood lipids
Masatoshi Mune
Lipids, 1991
View PDFchevron_right